Hardman Research: Q2 statement shows robust profitability
Q2 statement shows robust profitability: City of London has issued a trading statement for the first half of the 2017 financial year. As we noted previously, emerging market equities performed poorly in November, offsetting some of the good performance in the previous quarter and the MSCI Emerging Markets Index finished the half up 4.5%. City of London's FUM were $4.1bn at 31 December, up 2.5% from the $4.0bn as of the end of June. Investment performance has been challenging in the main emerging strategy market, with country allocation and underlying CEF performance contributing to a lagging of the market.
Please click here for the full report:
To contact us: Hardman & Co 11/12 Tokenhouse Yard London EC2R 7AS |
Contact: Dr Brian Moretta bm@hardmanandco.com Telephone: +44 20 7929 3399 Follow us on Twitter @HardmanandCo
|
www.hardmanandco.com
About Hardman & Co: For the past 20 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.
Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.
Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.